Dr. Delpriore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
268 Canal St
New York, NY 10013Phone+1 212-966-0228Fax+1 212-966-9330
Education & Training
McGaw Medical Center of Northwestern UniversityResidency, Obstetrics and Gynecology, 1987 - 1991
State University of New York Downstate Medical Center College of MedicineClass of 1987
University of Rochester Medical CenterFellowship, Gynecologic Oncology
Certifications & Licensure
GA State Medical License 2013 - 2027
NY State Medical License 1989 - 2027
HI State Medical License 2000 - 2026
IL State Medical License 1988 - 2026
IN State Medical License 2010 - 2025
OK State Medical License 2014 - 2016
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- Inequities in Surgical Access for Women With Endometrial Cancer in the United States: Opportunities for Surgical Justice.Regina Leonis, Thomas Chavez, Alex Caldwell, Giuseppe Del Priore, Roland Matthews
The American Surgeon. 2025-02-09 - Results of a phase I/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer.Charles L Wiseman, Jarrod P Holmes, Carmen Calfa, Shaker R Dakhil, Saveri Bhattacharya
Human Vaccines & Immunotherapeutics. 2024-12-31 - 5 citationsUtility of cell-based vaccines as cancer therapy: Systematic review and meta-analysis.Ankur Tiwari, Karl Alcover, Elizabeth Carpenter, Katryna Thomas, Julia Krum
Human Vaccines & Immunotherapeutics. 2024-12-31
Press Mentions
BriaCell Announces Resolution of Lung Metastasis in First Patient Treated with Bria-OTS™February 3rd, 2025- BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast CancerDecember 13th, 2024
- BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast CancerDecember 11th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
